| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 03/29/2007 | WO2007002635A3 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/29/2007 | US20070073068 Process for the preparation of (s)-glyceraldehyde acetonide |
| 03/29/2007 | DE19723275B4 Fluorcyclohexan-Derivate und flüssigkristallines Medium Fluorocyclohexane derivatives and liquid crystalline medium |
| 03/28/2007 | EP1767532A1 Method for producing fullerene derivative |
| 03/28/2007 | CN1938887A Electrolyte material for solid polymer type fuel cell, electrolyte membrane and membrane electrode assembly |
| 03/28/2007 | CN1938290A Chemical process |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/27/2007 | US7196209 Continuous process for the preparation of fructopyranose sulfamate derivatives |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | CA2019580C Novel methods of treatment using ranolazine and related piperazine derivatives |
| 03/22/2007 | WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| 03/22/2007 | WO2007032362A1 Substituted cycloalkene derivative |
| 03/22/2007 | WO2006133339A3 Monoamine re-uptake inhibitors and methods relating thereto |
| 03/22/2007 | US20070066623 Entry inhibitors of the hiv virus |
| 03/22/2007 | US20070066586 Aniline derivatives |
| 03/22/2007 | US20070066575 Methods and compositions for mitigating pain |
| 03/22/2007 | CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| 03/21/2007 | EP1373170A4 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts |
| 03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
| 03/21/2007 | CN1934141A Orthoester-protected polyols for low VOC coatings |
| 03/21/2007 | CN1931855A Compound 2-methylol-3-substituted phenyl propionic acid with optical activity and its resolving process |
| 03/21/2007 | CN1931854A Intermediate for synthesizing fasidotril and its synthesis use |
| 03/21/2007 | CN1931853A Compound 2-methylol-3-substituted phenyl propionic acid and its prepn process and use |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305839C Phenylglycine derivatives |
| 03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
| 03/15/2007 | WO2007028809A1 Method for the production of dioxolane |
| 03/15/2007 | US20070060656 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof |
| 03/15/2007 | CA2623594A1 Method for the production of dioxolane |
| 03/14/2007 | EP1040103B1 Anilide derivative, production and use thereof |
| 03/14/2007 | CN1930139A Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 03/14/2007 | CN1930109A Process for producing optically active fluorochemical |
| 03/14/2007 | CN1927831A N-sulfenate group diaromatic hydrazide derivative, preparation and application thereof |
| 03/13/2007 | US7189863 Process for producing trifluoromethyl-substituted 2-alkoxyacetophenone derivatives |
| 03/13/2007 | US7189749 Substituted phenoxyacetic acids |
| 03/08/2007 | WO2007027651A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/08/2007 | WO2006120639A3 Catalytic scriabine reaction |
| 03/08/2007 | US20070055081 Processes for production of alpha-aminooxyketones and alpha-hydroxyketones |
| 03/08/2007 | US20070054921 Substituted indoles and a process for preparing substituted indoles |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/08/2007 | US20070054883 Use controlling growth of quorum-sensing bacteria, controlling biofilm formation, including biofilm growth; cyclic borate, phosphate or sulfate compounds |
| 03/08/2007 | DE102005042505A1 Verfahren zur Herstellung von Dioxolan A process for preparing dioxolane |
| 03/08/2007 | CA2617495A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/07/2007 | EP1758908A1 Extraction of alkaloids from opium |
| 03/07/2007 | EP1758877A1 Substituted benzoylcyclohexandiones for use as herbicides |
| 03/07/2007 | EP1758852A2 Substituted cyclopentene compounds |
| 03/07/2007 | CN1926125A Process for production of cyclic carbonates |
| 03/07/2007 | CN1303084C New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186855 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 03/06/2007 | US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186726 Preferentially substituted calcium channel blockers |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186719 Antibacterial agents |
| 03/06/2007 | US7186414 Improved bioavailability; for oral and intracolonic administration |
| 03/01/2007 | US20070049755 Novel triazolo pyrimidine compounds |
| 02/28/2007 | EP1757608A1 New benzazepine derivatives, medicaments containing the same and their use in the preparation of medicaments |
| 02/28/2007 | EP1756058A1 Histamine-3 receptor antagonists |
| 02/28/2007 | EP1756044A1 Therapeutic compounds |
| 02/28/2007 | CN1922166A Method for the production of 3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol derivatives |
| 02/28/2007 | CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1922125A Alkyl acetal compound, process for producing the same, and lubricating oil composition |
| 02/28/2007 | CN1922123A Polyacene compound and organic semiconductor thin film |
| 02/28/2007 | CN1302339C Photo sensitive resin composition |
| 02/28/2007 | CN1302016C Fulvene, metallocene catalysts and preparation method thereof, and preparation of polyolefines copolymer using the same |
| 02/28/2007 | CN1301974C Muller Klaus-helmut |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
| 02/27/2007 | US7183423 Reacting an alcohol with an acrylic acid or acrylate compound to form an alpha-hydroxy-gamma-butyrolactone compound, using N-hydroxyphthalimide as catalyst for example |
| 02/27/2007 | US7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 02/27/2007 | US7183008 Electroluminescent materials |
| 02/22/2007 | WO2007020964A1 Method for producing 4-halocatechol compound |
| 02/22/2007 | US20070043225 Method for the production of 3-amino-5-(hydroxymethyl) cyclopentane-1,2-diol-derivatives |
| 02/22/2007 | US20070043187 Perfluoro-4-methyl-2-methylene-1,3-dioxolane, for example, prepared by reacting mixture of 2-chloro-1-propanol and 1-chloro-2-propanol with methyl trifluoropyruvate; useful as an optical or electrical materials |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | CN1918103A Method for producing 2,5-dimethylphenyl acetic acid |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1915964A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179800 Cannabinoids |
| 02/15/2007 | WO2007017093A1 Substituted 2-benzyloxy-benzoic acid amide derivatives |
| 02/15/2007 | WO2007017092A1 Substituted 4-benzyloxy-benzoic acid amide derivatives |
| 02/15/2007 | US20070037973 reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction |
| 02/15/2007 | US20070037943 Novel perfluoroalkyl vinyl ether compound, process for preparing copolymer by using the compound, and optical plastic materials comprising copolymer prepared by the process |
| 02/15/2007 | US20070037890 Cannabinoids |
| 02/15/2007 | US20070037864 Intermediates for the preparation of lipoxin A4 analogs |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | DE102005036696A1 Arylamine und deren Acetale Arylamines and their acetals |
| 02/15/2007 | CA2618888A1 Acyltryptophanols for fertility control |
| 02/15/2007 | CA2616451A1 Substituted benzyl derivatives as gsk-3 inhibitors |
| 02/14/2007 | EP1751091A2 2-amino- and 2-thio-substituted 1,3-diaminopropanes |
| 02/14/2007 | EP1751089A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/14/2007 | CN1914189A Spiro-benzodioxoles and their use as CB1 antagonists |
| 02/14/2007 | CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists |
| 02/14/2007 | CN1911926A Synthesis method of (4R,5R)-4,5-bi (aminomethyl)-1,3-bioxyamyl cyclic kind compound |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |